NRXP
NRX Pharmaceuticals, Inc.Closed2.70−0.15 −5.26%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 2.73 +1.06%
Open
2.85
Prev close
2.85
Day range
2.682.85
52-week range
1.625.06
Volume
551.77K0.65×
Mkt cap
116.90M
P/E ttm
—
Fwd P/E
-7.71
EPS ttm
-0.5800
Div yield
0.00%
Earnings
—
From 52w high
−46.59%
NRXP earnings and estimates
NRXP Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 12
After the close
EPS consensus
$−0.15
range −0.15 – −0.15
EPS growth vs year ago
+70.4%
year ago −0.51
Revenue consensus
$1.29M
+431.1% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±11.4%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 14, 2026 AMC | −0.24 | −0.13 | −87.77% | $1.10M | +4.9% | +8.9% |
| Mar '26 | May 15, 2026 AMC | −0.04 | −0.11 | +59.64% | $1.07M | −5.0% | −1.8% |
| Dec '25 | Mar 23, 2026 AMC | 0.18 | −0.08 | +329.13% | $983.00K | +20.3% | +18.1% |
| Sep '25 | Nov 14, 2025 AMC | −0.51 | −0.02 | −2938.39% | $242.00K | −15.3% | −14.5% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.15 | — | +70.4% | $1.29M | +431.1% | −0.08 −87.5% | −0.08 −87.5% | 0 / 1 |
| Next quarter Dec 2026 | −0.17 | — | −192.7% | $2.57M | +161.6% | −0.03 −466.7% | −0.03 −466.7% | 0 / 1 |
| Current year Dec 2026 | −0.80 | — | +40.3% | $5.61M | +357.9% | −0.36 −122.2% | −0.36 −122.2% | 0 / 1 |
| Next year Dec 2027 | −0.35 | — | +56.3% | $90.17M | +1507.3% | 0.50 −170.0% | 0.50 −170.0% | 0 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.29 | −0.43−0.15 | 2 | 0 / 1 |
| Dec 2026 | −0.34 | −0.50−0.17 | 2 | 0 / 1 |
| Mar 2027 | −0.24 | −0.30−0.17 | 2 | 0 / 0 |
| Jun 2027 | −0.14 | −0.15−0.13 | 2 | 0 / 0 |
| Sep 2027 | −0.08 | −0.10−0.05 | 2 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −1.14 | −1.48−0.80 | 2 | 0 / 1 |
| Dec 2027 | −0.43 | −0.50−0.35 | 2 | 0 / 1 |
| Dec 2028 | 0.15 | — | 1 | 0 / 0 |
| Dec 2029 | 0.71 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.